Skip to content

Bruce Booth, Director at Kymera Therapeutics, sold KYMR on Jun 22, 2026

Data as of Oct 16

▼ SELL$140K1,341 shares at $104.38Bruce Booth DirectorKYMR Kymera Therapeutics, Inc.
Watch KYMR
Traded
Jun 22, 2026
Disclosed
Jun 22, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Bruce Booth, Director at Kymera Therapeutics, sold KYMR on Jun 22, 2026TRADEDDISCLOSED
KYMRSimilar stocks (XLV — its sector index fund), rebased to KYMR's price on the disclosure day
KYMR since disclosure
+5.4%
after the sale
Similar stocks (XLV) since disclosure
+17.8%
XLV — its sector index fund

Change in closing price from Jun 22, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$1Mdisclosed Jun 22 · filed the same day
  2. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$265Kdisclosed Jun 22 · filed the same day
  3. ▼ SELLBruce Booth DirectorKYMR Kymera Therapeutics, Inc.$1.9Mdisclosed Jun 22 · filed the same day

See every trade on KYMR →